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Abstract
Purpose: The purpose of this study was to distinguish differences in gene expression between cells cultured
from the juxtacanalicular trabecular meshwork ( JCTM) and those from Schlemm’s canal (SC), to gain clues to
differences between those cell types, and to add to our baseline knowledge of gene expression differences in
these cell types for later comparison between cells from nonprimary open-angle glaucoma (POAG) and POAG
outflow tissues.
Methods: A set of JCTM and SC cells was cultured from each of 2 donor eyes by an explant method, grown to
passage 3, and frozen in liquid nitrogen. The cells were thawed, total RNA was extracted, and the probes made
from total RNAs were hybridized to MICROMAX human cDNA microarray slides in 2 separate trials. Dif-
ferentially expressed genes were analyzed using PubMed, Prosite, and IPA software, and the expression of
several of the genes including intercellular adhesion molecule-1 (ICAM-1), tenascin, and b-spectrin was as-
sessed by immunofluorescence.
Results: Schlemm’s canal cells differentially expressed ICAM-1, spectrin, complement, fibulin-1, and several
genes consistent with an endothelial origin in both arrays, while the JCTM cells more often overexpressed genes
consistent with contractile, matrix function, and neural character. At the same time, many genes highly ex-
pressed in the first array were not highly overexpressed in the second. One highly overexpressed gene in the
JCTM in both arrays, that for heparan sulfate 3-O-sulfotransferase-1 precursor, is thought to be somewhat
unique, and could affect the glycosaminoglycan functionality in the extracellular matrix (ECM).
Conclusions: We found generally good agreement between the 2 array trials, but some contradictions as well.
Many of the genes overexpressed in each cell type had been described in earlier work, but several were new.
Tables of genes, grouped by cellular function, and the complete datasets are provided for the development of
new hypotheses.
Introduction
The aqueous outflow pathway is considered to bethe likely site of the increased hydrodynamic resistance
to outflow associated with increased intraocular pressure in
primary open-angle glaucoma (POAG).1–6 The normal and
abnormal functioning of the cells that line Schlemm’s canal
(SC) and those that generate, maintain, and line the tra-
becular meshwork (TM) are therefore of continuing interest.
We prepared cultures of SC and juxtacanalicular, cor-
neoscleral, and uveal TM cells by fine dissection and ex-
plant culture, and were able to obtain cells that were typical
for each tissue. Our long-term goal was to compare cells
from each subdivision of the outflow pathway with com-
parable cells from POAG donor eyes. Our early experience
had found that cells obtained from POAG tissue grew more
slowly, and individual cells had aberrant vesicle movements
and actin-based motility. However, this pattern was not
apparent when POAG anterior segments were supported
with pH-stabilized growth medium within 12 h of death. In
that case, cells from each section of POAG eyes grew as
well as and sometimes better than comparable non-POAG
tissue. The present study was undertaken in 1999–2000
as a baseline comparison to test the reproducibility of the
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differential dissection method in non-POAG tissue, and to
determine whether recognizable characteristics of the spe-
cific cell types would persist for several generations in
culture. We compared the relative gene expression of SC
and the juxtacanalicular TM (JCTM) cells derived from
nonglaucomatous donors by the explant method. We tested
2 sets of cells from 2 donors, and 2 differential cDNA
screens. The screens differed by only 4 genes in total out of
2,400. We particularly looked at those genes that were most
differentially expressed in both assays. The patterns ob-
tained generally support the utility of the subdivided tissue
process, while the patterns themselves highlight interesting
differences between the SC and JCTM cells that may be
exploited in future studies.
Methods
Cells were isolated and cultured by our previously pub-
lished explant method,7 with several additional steps to
isolate the finer JCTM from the corneoscleral and uveal
layers. The principal difference was not using blunt dis-
section to remove all of the TM at once, but rather using fine
forceps to separately tease apart short, *1-cm-long strips of
uveal, corneoscleral, and then JCTM. Each was placed into
a shallow sterile plastic culture dish, a sterile cover glass
was placed firmly over the tissue, and medium was added.
The JCTM was usually removed without a portion of the
inner wall, but when a small portion of the canal was re-
moved with the JCTM, the orientation of the tissue was
recorded, and only the JCTM side was used to grow JCTM
cells. To remove SC, deeper radial cuts were made through
the canal about 1 cm apart. A deeper circumferential cut was
then made between the canal and the iris root, into the
limbal stroma. Finally, a fresh scalpel was used to make a
‘‘filet’’ cut ‘‘under’’ the canal, parallel with the outer wall,
to excise the walls of the canal. The canal was subsequently
spread open and placed face down on the tissue culture
plastic. Our identification of SC cells was at first primarily
dependent on the subdivision and orientation of the tissue,
and our knowledge of what the TM cells look like. Over
many dissections, the SC cells were found to consistently
exhibit a canoe-like fusiform shape, most evident in refer-
ence 7. They also formed regular side-to-side junctions with
little overlap. The JCTM cells were essentially TM-like in
form, somewhat ‘‘triangular’’ in shape, did not make as
consistent and regular intercellular junctions, and appeared
smaller on average than uveal TM cells. Cells were frozen
back before reaching full confluence after passage 3 and
stored on liquid N2 until shipment on dry ice to the Yue
laboratory for extraction. Immunofluorescence microscopy
was performed using the cells from the older donor that had
been frozen at passage 3. Cells were thawed, passaged one
more time and plated onto gelatin-coated glass coverslips.
When confluent for at least 1 day, the cells were fixed with
4% formaldehyde and stained using monoclonal antibodies
to ICAM-1 (R & D Systems, Minneapolis, MN), and
polyclonal antibodies to tenascin (R & D Systems) and
spectrin (Sigma Chemical, St. Louis, MO) and the appro-
priate secondary antibodies.
Total cellular RNA was extracted from 2 sets of JCTM
and SC cells (2–3 vials, each containing approximately
500,000 cells per vial), 1 set from each of 2 donors. For the
first test, we compared expression of JCTM and SC cells
from an 18-year-old normal human donor using an early
version of the MICROMAX Human cDNA Microarray
System I, AB581 (NEN, Boston, MA). For the second test,
cells were from a normal 68-year-old donor and a second
version of the array was used (AG694). Surprisingly, cells
from older donors grew successfully at rates similar to those
from younger donors, as well as eyes from POAG donors, if
the eyes were opened and placed in medium within 12 h of
death. Thus, it was of interest to observe whether the simi-
larity in observed growth would be reflected in similarities
in the gene expression levels of donors of such disparate
ages. RNA was extracted using the RNeasy Mini Kit
(Qiagen, Valencia, CA). The integrity of RNA was assessed
by visualization of intact 28S and 18S ribosomal RNA
on 1% agarose gels. The OD260/280 ratio was 1.7–1.9. The
MICROMAX System I comprised 2 identical 1’’ · 3’’ glass
microarrays, each pre-spotted with 2,400 or 2,396 known
genes. Except for a small number of plant control genes, all
genes were from over 50 human cDNA libraries. In this
microarray, over 10 tissue sources were represented, over
40% of which were full-length genes. The 2,400 genes in the
first array and 2,396 genes in the second were characterized
functionally based on Prosite ‘‘motif’’ research, and were
readily identifiable through a gene database on NEN’s
website, and linked to the NIH GenBank. MICROMAX can
FIG. 1. Bar graphs of the overall
fraction of genes that were relatively
overexpressed at three cutoff levels:
‡ 2.5, 2.0, or 1.5-fold in Schlemm’s
canal (SC) over juxtacanalicular tra-
becular meshwork ( JCTM) or JCTM
over SC cell type. yo, year-old.
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detect as few as 1.2 copies per cell of a gene starting with
RNA from 2.0 · 105 cells.
Total RNA (4mg) from JCTM cells was used to make
dinitrophenyl (DNP)-labeled cDNA employing reverse
transcriptase and nucleotide analogs. RNA (4 mg) from SC
cells was used to synthesize biotin-labeled cDNA. The
quality and efficiency of labeled cDNAs was checked using
membrane-based chemiluminescence methods. Equal vol-
umes of DNP and biotin cDNA samples were mixed and
applied onto 1 microarray slide. Hybridization was done
overnight at 65C. After hybridization, the slide was washed
with 0.5x SSC (sodium chloride–sodium citrate buffer),
0.01% sodium dodecyl sulfate (SDS) (wt/vol) for 5 min,
0.06x SSC, 0.01% SDS for 5 min, and 0.06x SSC for 2 min.
The hybridized DNP and biotin-labeled cDNAs were se-
quentially detected with a series of conjugate reporter
molecules using the NEN’s Tyramide Signal Amplification
system. Each of the 2 fluorescent reporter molecules (cya-
nine 3 or Cy3 and cyanine 5 or Cy5) was associated with the
hybridized material from each of the starting samples, Cy3
with JCTM and Cy5 with SC. Microarray slides were sent
back to NEN for scanning and data processing. A ScanArray
3000 laser detection system (GSI Lumonics Inc., Water-
town, MA) was used to scan and report the relative quantity
of the 2 dyes at any given gene spot. The ratio of each spot
was calculated by dividing the volume of Cy5 channel with
the volume of Cy3 channel. Normalization factor was cal-
culated based in the ratios obtained by 50 control gene spots
or by densities of all gene spots. The factor was nearly
identical. A Cy3/Cy5 ratio larger than 1.0 indicates that the
JCTM samples were greater in expression than the SC
samples and a Cy5/Cy3 ratio >1.0 was indicative of SC
cells having a greater expression. We looked at the number
of genes relatively overexpressed in 1 cell type at ratios of
1.5 and greater, 2 or greater, and 2.5 or greater over the
other cell type (‘‘cutoff ratios’’) using Excel (Microsoft,
Inc.), and compared these values in the 2 donor runs. We
then compared the actual genes that were overexpressed in
each at the higher cutoffs. We grouped genes overexpressed
in each cell type by putative function using the gene name
and PubMed and the Prosite software, to group genes by
general relationships. Finally, we used a commercial soft-
ware package, Interactive Pathway Analysis (IPA), (Ingenuity
Systems, Inc., Redwood City, CA) to obtain a third per-
spective on the relationships of relatively overexpressed
genes in both arrays (at the 2 or greater cutoff ratio) in terms
of signaling pathways, metabolic pathways, molecular net-
works, and biological processes.
FIG. 2. Staining for human intracel-
lular adhesion molecule 1 (ICAM-1),
tenascin, and b-spectrin in confluent
SC and JCTM cultures from the same
donors. Antibodies to ICAM-1 (A,B),
tenascin (C,D), and b-spectrin (E,F)
were used to stain cultures of SC
(A,C,E) and JCTM (B,D,F) cells. As
evident in panel A, staining for
ICAM-1 in SC cells was sporadic,
being seen brightly in only a small
proportion of cells, but was not ob-
served in any structures stained in
JCTM cells (B). Staining of tenascin
protein was observed in outlines of SC
cells throughout the culture (C). Te-
nascin was also present in JCTM cells,
but appeared primarily between the
ventral surface of each cell and the
glass surface. Areas of exclusion of the
stain appeared to outline the pattern of
actin stress fibers within the cell (D).
Staining of b-spectrin was seen in both
cell populations to be primarily in the
lamellapodial regions, but was more
widely and uniformly observed in SC
cell cultures (E) than JCTM (F). Three
pairs of cultures showed similar results.
Bar = 10mm.
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Results
We were first interested to know whether the 2 indepen-
dent array experiments, using cells from a very young and
an older donor, would yield consistent results. As an over-
view, we looked at the overall proportion of genes that were
expressed more highly in 1 cell type relative to the other.
Three ‘‘cutoff’’ ratios were used. A 2.5-fold ratio or greater
was the most stringent, and 2- and 1.5-fold ratios were also
compared. Figure 1 shows the comparisons at each ratio.
Although we used SC and JCTM cells from donors of
widely different ages, the results at this level were re-
markably consistent. The percent of genes overexpressed in
SC relative to JCTM cells at each fold difference was about
3-fold smaller in both sets than the relative overexpression
seen in JCTM. Moreover, the proportions were similar in
both sets. These general trends lend support to the repro-
ducibility of the assay, as well as the differential dissection
protocol. On the other hand, it is interesting that what could
be interpreted as the ‘‘tails’’ of what one might expect to be
a normal distribution of ratios is so asymmetric. This most
probably reflects a nonrandomness in the pattern of genes
chosen in the Micromax array. Also interesting was that,
while the proportion of genes overexpressed in JCTM rel-
ative to SC was greater in both arrays, the genes that were
markedly overexpressed (>2-fold) in both arrays were much
larger for the SC cells (Tables 1 and 2). This may reflect
more heterogeneity in the JCTMs, or perhaps a difference in
donor ages makes more of a difference in the JCTMs (see
Discussion).
Table 1 shows the gene transcripts overexpressed above
2-fold in JCTM cells in both arrays. They are presented
in the approximate order of overexpression in both ar-
rays. Alkali myosin light-chain 1 is associated with skeletal
muscle and other muscle cell types.8 Heparan sulfate 3-O-
sulfotransferase-1 precursor is an interesting protein related
to glycosaminoglycan function and thus might affect hy-
drodynamics near the surface of the TM9 (see Discussion).
Several of the transcripts are associated with neuronal ori-
gins. Microtubule-associated t protein is enriched in brain
neurons, and is a core component of neurofibrillary tangles
related to Alzheimer disease.10,11 MEGAP/srGAP3b (KIAA0411)
is important in brain development,12 and NeuroD has been
associated with inhibition of cell motility in glioma.13,14
Thus, there is some indication of neuronal character in the
genes overexpressed in the JCTM. This is discussed further
below.
Even though there were fewer genes overexpressed in SC
cells relative to JCTM, many more genes were found
strongly overexpressed in both arrays (Table 2). SC cells
expressed genes such as ICAM-1, hexabrachion (tenascin),
b-spectrin, high-density lipoprotein binding protein
(HDLBP), and complement proteins that are relevant to
functions of the vascular endothelium. ICAM-1 is expressed
on the surface of endothelial cells and macrophages and
plays an important role during inflammation by facilitating
the tight adhesion of leukocytes to the vascular wall.15
Hexabrachion is an anti-adhesive ECM protein with a fas-
cinating 6-armed structure.16,17 It is strongly associated with
the basement membrane of the vascular endothelium, and
may play a role in epithelial-to-mesenchymal transition.18,19
Tenascin is not in Table 2 as a separate entry, but it is the
same molecule as hexabrachion, which was highly over-
expressed in both arrays.17 Tenascin (presumably hybridiz-
ing with a different section of the gene sequence) was
separately found very highly overexpressed in the AG694
array but not AB581. This may reflect the age of the donors,
or an inherent variability in the expression. HDLBP assists
uptake of high-density lipids and lipoprotein lipase in the
vascular system.20 Complement proteins provide the link
for immune cells to bind to the endothelium and can acti-
vate endothelial cells to induce production of cytokines and
pro-inflammatory responses, and may also connect to the
thrombotic cascade.21 Spectrin is a prominent component of
the plasma membrane cytoskeleton in endothelial cells,
where it has been suggested to have a role in regulation of
store-operated calcium entry.22 Of note is that, among the
cadherin family junctional genes being expressed, VE-
cadherin was not tested in these arrays, nor was PECAM,
both reported to be expressed in SC cells in culture.23,24
Fibulin 2, also reported in SC cells,24,25 was also not tested
in this array, but fibulin 1 was much higher in SC cells. The
fibulins are interesting as an elastic component of the ECM
and basement membrane.26,27 As such, differences in ex-
pression of this glycoprotein could affect the elastic ‘‘tone’’
of the cribriform ECM. Thus, our results are consistent with
Table 1. Genes Highly Expressed ( > 2.0 Fold) in Juxtacanalicular Trabecular Meshwork Cells
Relative to Schlemm’s Canal Cells in Both Array Experiments
Accession # Gene product
M20642 Alkali myosin light-chain 1—skeletal muscle related
AF019386 Heparan sulfate 3-O-sulfotransferase-1 precursor
Y15409 Putative glucose 6-phosphate translocase
X14474 Microtubule-associated t protein—brain—found in neurofibrillary tangles
D50419 OTK18—possible antiretroviral transcriptional factor
U40490 Nicotinamide nucleotide transhydrogenase, nuclear gene encoding mitochondrial protein
D11094 MSS1—mammalian suppressor of sgv1
M12783 C-sis/platelet-derived growth factor 2
M83670 Carbonic anhydrase IV
Y07512 Type I beta cGMP-dependent protein kinase (EC 2.7.1.37)
AB007871 KIAA0411- MEGAP/srGAP3b—brain development—role in mental retardation
M29064 hnRNP B1 protein
U07361 Sorbitol dehydrogenase gene—loss related to cataract
U59309 Fumarase precursor (FH) mRNA, nuclear gene encoding mitochondrial protein
D82347 NeuroD—cerebellum—inhibits motility in glioma
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an endothelial identity of the SC cells.5,23,24,28 One inter-
esting question is what role chitinase family proteins play in
the outflow pathway. Liton et al. showed that the chitinase
3-like 1 gene was strongly overexpressed in TM cells rela-
tive to SC.25 We find that the gene M80927 was highly
overexpressed in SC cells, and it is also a member of the
chitinase family of glycoproteins.
We subsequently categorized the genes that were ex-
pressed differentially in either JCTM (Supplementary Table
S1; Supplementary Data are available online at www
.liebertpub.com/jop) or presumptive SC (Supplemental
Table S2) cells by their known or postulated general cellular
functions using Prosite software (http://www.uniprot.org/)
and reading about each gene using Pubmed. Within each
category, the genes were listed in descending orders of
differential expression using only the results from the
AG694 array from the older donor, as more representative of
an aging outflow pathway. Comparing the results from
Supplementary Tables S1 and S2, one can discern interest-
ing contrasts and similarities between the 2 cell types. For
instance, SC cells differentially overexpressed both a and
b actin–myosin components, and cell junction and tight
junction proteins including cadherin-4, and ZO-1, consistent
with a barrier function to paracellular flow and a role for
ZO-1.29,30 Differential expression of these junctional pro-
teins should be taken as a minimum, in that the cells were
harvested within a day of reaching confluence. On the other
hand, the relative abundance of N-cadherin in SC cells
seems unexpected. As discussed above, SC cells appeared to
be enriched with ECM genes, especially tenascin and col-
lagen types IV and VI. Although different in specifics, both
cell types also express proteases and inhibitors that are re-
sponsible for modulation of the ECM and basement mem-
branes. Understanding the pattern of relative overexpression
of these proteases and their targets may prove relevant to
existing models and ideas of how the ECM and its regula-
tion might affect outflow.31–34 Also, each cell population
expressed in greater amounts a different set of genes for
water and ion channels. These channels are of importance
for fluid transport and regulation of cell size and thus could
directly impact outflow functions.35–39 At the bottom of both
Supplementary Tables S1 and S2, we grouped the genes
that are associated with brain or neuronal development or
function. The results show that the JCTM cells over-
expressed 21 neuronal-related genes down to 1.9x over SC,
while the SC cells overexpressed 6 genes at that same level.
This is again consistent with the neural crest origin for the
TM and possibly the JCTM (see Discussion). We also found
many more genes with functions that are related to the
vascular endothelium in the SC cells (Supplementary Table
S2), but few specifically endothelial in the JCTM.
In addition, we used IPA, a commercial software package
(see Methods), to obtain an additional perspective on the
relationships of relatively overexpressed genes, using the 2
or greater cutoff ratio for both arrays, in terms of signaling
pathways, metabolic pathways, molecular networks, and
biological processes. These are presented in Supplementary
Table S3 for relatively overexpressed in JCTM, and Sup-
plementary Table S4 for those overexpressed in SC. The
molecular and cellular functions of the abundant genes in
JCTM cells included carbohydrate metabolism, cellular as-
sembly and organization, cell morphology, and molecu-
lar transport. The networks of genes highly expressed in SC
Table 2. Genes Overexpressed at > 2.5 Fold
in Schlemm’s Canal Cells in Both Arrays
Accession # Gene product
M80927 Glycoprotein—member of chitinase protein
family
U03877 Extracellular protein (S1-5) fibrillin-like
protein
L13698 gas1 gene—growth suppressor
X73478 hPTPA—activates the tyrosyl phosphatase




X06990 Intercellular adhesion molecule-1
X04701 mRNA for complement component C1r
X03445 mRNA for nuclear envelope protein lamin
C precursor
M64098 High-density lipoprotein binding protein
X53416 Actin-binding protein (filamin)
M22960 Protective protein
M63959 a-2-Macroglobulin receptor–associated protein
AF000381 Nonfunctional folate-binding protein
L37033 FK-506 binding protein homologue
(FKBP38)
AF014807 Phosphatidylinositol synthase (PIS)
U22526 2,3-oxidosqualene-lanosterol cyclase
M24097 MHC class I HLA-C-a-2 chain and
alternative, clones 4 and 10
D67025 Proteasome subunit p58
X72018 hTGR 1 mRNA (NAGR1)
M73778 PML-1 protein
L14754 DNA-binding protein (SMBP2)
D26181 Novel protein kinase
M33294 Tumor necrosis factor receptor
Z74615 Prepro-a1(I) collagen
M64571 Microtubule-associated protein 4
U58856 Chromosome 17 unknown product
Z29481 3-Hydroxyanthranilic acid dioxygenase
D21089 XP-C repair complementing protein (p125)
U29089 Proline arginine-rich end leucine-rich repeat
protein
X64364 M6 antigen
J02939 Membrane glycoprotein 4F2 antigen
heavy-chain mRNA
M27110 Proteolipid protein mRNA
L42024 MHC HLA-B39
X64330 ATP-citrate lyase
M23725 M2-type pyruvate kinase
L19871 Activating transcription factor 3
M62994 Thyroid autoantigen (truncated
actin-binding protein)
X58141 Erythrocyte adducin a subunit
M59807 NK4
X87949 BiP protein
M88338 Serum constituent protein (MSE55)




X62137 Anion exchange protein 2
X98893 TBP-associated factor, TAFII68
M14221 Cathepsin B proteinase
L77964 ERK3 protein kinase
hPTPA, human phosphotyrosyl phosphatase activator; MHC, major
histocompatibility complex; hTGR, human thyroid glucosamine
receptor; PML, promyelocytic leukemia; TBP, TATA binding protein.
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cells included carbohydrate metabolism, cell death and
survival, cellular development, and cardiovascular system
development and function.
Finally, we tested the binding of antibodies to several
extracellular structural proteins identified in the arrays as
being differentially expressed in SC cells (Table 2) using
immunofluorescence microscopy. Our purpose was to de-
termine the extent of correlation of the differentially ex-
pressed genes with the expression of actual proteins in
cultured cells, while recognizing that there are many points
of control between mRNA levels and final protein levels in
cells.40,41 Antibodies to ICAM-1 (Fig. 2A, B), tenascin (Fig.
2C, D), and b-spectrin (Fig. 2E, F) were used to stain
confluent cultures of JCTM (Fig. 2B, D, F) and SC cells
(Figure 2A, C, E). As evident in Fig. 2, staining for ICAM-1
in SC cells was sporadic, being seen brightly in only a small
proportion of cells (1 highly expressing cell is shown in Fig.
2A). On the other hand, it was nonexistent in JCTM cells.
ICAM staining in SC cells was found around the edges and
top (dorsal) surface, and in several instances, staining was
found on filopodial-like projections between neighboring
cells. Interesting differences between the 2 cell types were
also seen with the tenascin staining. The staining in SC cells
was more intense than that in JCTM cells. The staining
pattern was also different. In SC culture, tenascin staining
was observed around the edges of each cell, in dramatic
ribbons consistent with extensive extracellular buildup (Fig.
2C). JCTM cells showed almost none of the ribbon-like
staining between cells (Fig. 2D). Rather, in places, a very
fine, powdery staining between the ventral surface of the
cells and the coverglass surface was seen. The bare areas in
the powder were very reminiscent of the patterns of F-actin
filaments seen in TM cells such as the cross-linked F-actin
networks shown by Clark et al.42 We surmise that tenascin is
secreted ‘‘ventrally’’ in JCTM cells, but is excluded from
the closer contacts between the ventral membrane and glass
surface underneath the stress fibers. Why and how this might
take place is an interesting question. Fig. 2E and F indicate
that both cell types expressed b-spectrin. SC and JCTM
cultures both showed areas of spectrin staining, with the
areas of most stain found in the lamellipodial areas. It ap-
peared that the level of stain and number of cells with stain
was less in JCTM cells. The immunofluorescence results
thus are in reasonable agreement with the array data.
Discussion
The experiments described above were carried out using
early forms of the Micromax arrays, to ascertain the repro-
ducibility of the method and to gain clues to the cellular
basis of outflow pathway physiology. Since the time they
were carried out (1999–2000), many studies have clearly
shown the utility of the differential expression method, as
well as approaches that quantify the relative level of tran-
scripts from a particular tissue or culture individually.25,43–48
Our results are consistent with many of these studies, and
also show some contrasts (discussed below). We also note
that the level of agreement between arrays in our study was
good, but not perfect. Some genes that were overexpressed
in JCTM in the second array, AG694, using cells from the
older donor, were often less overexpressed in the first array,
or even were higher in SC cells. This can be appreciated
most easily by searching for a gene of interest in the final
supplemental spreadsheet (Supplementary Table S5), which
is the entire raw dataset from both arrays. The spreadsheet is
shown with 3 different sortings. Sheet 1 is sorted alphabet-
ically by gene name, so each row shows the results from the
same gene in both arrays. Sheet 2 is sorted by expression
ratio, low to high based on the JCTM/SC value, for each
array independently. Sheet 3 shows both arrays sorted by the
expression ratio found in AG694, and thus the genes are still
aligned in each row. Using these, one can quickly see
whether the arrays showed consistent results for a particular
gene, and also assess the values for each. We are not sure at
present whether the differences between array results reflect
differences in the ages of the donors, or inherent variability
in the methods used, yet the many interesting correlations
found are worth noting.
Studies that quantify the relative amounts of specific
transcripts in the TM from whole eyes,43–45 cultured TM
cells,25,46 or excised tissue47 have identified many candidate
genes of interest, while differential array experiments have
been used to identify differences caused by dexamethasone
treatment in TM cells,48 cultured TM cells versus excised
TM,46 and SC versus TM cell cultures.25 Our results support
many of the previous findings, as described in Results, but
conflict with others. For example, we found an increase in
mRNAs for GAPDH (M33197) and ferritin light and heavy
chain in SC cells in both arrays, while Gonzalez et al. found
that whole perfused eyes showed high levels of expression
of these genes in the TM.43 GAPDH was just over 2-fold
higher in SC/JCTM in both arrays (Supplementary Tables
S5), while ferritin heavy chains (M11146; L20941) and
light chain (M11147) were an average of 2.5-fold higher in
SC cells (Supplementary Table S5), but 1 value was just
below the 2x cutoff for Table 2 in one or the other array for
each gene, so they were not included in that Table. This
reflects the drawback of the differential array method, in that
both cell types showed the transcripts, but in our hands the
SC cells had relatively higher levels. We did not quantify
the absolute number of transcripts. On the other hand, the
TM cells might have lost expression of those genes more
quickly in culture, as pointed out by Liton et al.46 The most
directly comparable study to the present work is that of
Liton et al.,25 but our earlier-generation array did not in-
clude many of the genes tested in that study. Thus, our data
may provide additional and not overlapping information.
An interesting connection to the ECM we see in our data
is the overexpression of heparan sulfate 3-O-sulfotransferase
precursor in JCTM in both arrays (Table 1). The 3-O
transferases promote sulfation of glucosamine at the 3-O
position of heparan sulfate, and there is a recent recognition
that that reaction may serve to modulate antithrombin ac-
tivity, lymphocyte binding, growth-factor binding, and
possibly other important reactions at the cell membrane or
extracellular space.9 It would be of interest if the modulation
of heparan sulfate by this transferase affected the known
binding of heparan sulfate to the Hep II domain of fibro-
nectin.49 As shown by Santas et al., perfusion of excess
amounts of isolated Hep II domain can modulate outflow.50
Perhaps the degree and sites of heparan sulfate ion can af-
fect the binding of syndecans to fibronectin at the Hep II
site, possibly affecting outflow.
We saw no difference in the baseline expression of
myocilin in our cell populations. This is not consistent with
a previous finding of a higher baseline level of myocilin
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protein in more uveal TM cultures compared with SC cul-
tures,7 but may imply that regulation of baseline myocilin
protein may take place at levels other than that of steady-
state RNA expression.
Provocative associations have been noted between Alz-
heimer dementia and glaucoma.51–57 Although these are
generally assumed to be connected via a common pathway
of neuronal degeneration, it is intriguing to postulate that
the underlying causes of some forms of these insidious
diseases of aging might be via common or related effects
within the outflow pathway. Consistent with this possibility,
the JCTM cells showed relative overexpression of microtubule-
associated t protein, a constituent of neurofibrillary tan-
gles.9,10,58–60 JCTM cells also expressed a gene bearing
missense mutation in Alzheimer and Adaptor protein X11b
that binds precursor of amyloid, a primary component of
senile plaques (Supplementary Table S1; array 2).60,61 In SC
cells, 4 other genes related to amyloid were found to be
enriched (Supplementary Table S2). Thus, the ‘‘raw mate-
rial’’ for a pathology that is mechanistically related to
Alzheimer dementia is present in the cells of the outflow
pathway, but whether these proteins play a role, either in
cell function or via the secretion of misfolded proteins, is
not known. Understanding possible connections between the
etiology of Alzheimer and POAG will be especially inter-
esting to investigate in the future.
Our results are largely consistent with the TM cells we
cultured being derived from the neural crest.62,63 Three out
of the 15 genes in Table 1, for example, appear to be neu-
ronally related, and 21 genes are neuronally related in
Supplementary Table S1 compared with 6 in the SC cells in
array 2. On the other hand, many of the genes overexpressed
in SC relative to JCTM in both arrays (Table 2) are con-
sistent with an endothelial cell type, and several additional
endothelial-related genes were identified in Supplementary
Table S2. This is not proof of identity, but is consistent with
extensive work showing the endothelial nature of SC.64,65
The origin of JCTM cells from neural crest would be con-
sistent with our having cultured the ‘‘deepest’’ (closest to
SC) layers of the meshwork, but not the cells embedded
within the ECM. By removing the uveal and corneoscleral
portions of the meshwork, we endeavored to culture those
cells closest to the inner wall. On the other hand, we did not
digest the ECM, or finely dice the ‘‘cribriform’’ layer, and
so we endeavored to select for cells that were accessible to
the surface of the trabeculae and cul-de-sacs. However, gi-
ven the apparent greater variability in the JCTM cultures, it
may be that we were only partially successful in isolating a
single population. Further work will be necessary to deter-
mine whether there are still more subdivisions to be dis-
tinguished within the juxtacanalicular region, between cells
that are fully embedded within the cribriform ECM matrix,
termed ‘‘fibroblasts’’ by Grierson et al.66 and JCTM cells in
recent reviews,67,68 and those cells with areas of their
membrane that are exposed to the outflow channels.
As the site of aqueous humor drainage, and of the in-
creased outflow resistance in POAG, the TM, SC, and the
ECM, what they construct and maintain are of essential
interest. Is proper outflow resistance maintained primarily
through adjusting the composition or structure of the ECM,
through adhesion to or production of specific glycosami-
noglycans, through secreted proteins, or through adjustment
of cellular permeability, stiffness, or via the application of
contractile forces to the ECM or to other cells? If, as is
likely, it is through combinations of these and other factors
in a complex network, it is still useful to discern the main
components that influence outflow and whether there is a
common final pathway to POAG. Differential expression
assays have the characteristic of giving an impression of
what the cells being compared are like, while in fact they are
limited to assessing only the contrasts between cell types.
The present study shows fairly large differences between 2
very different cell types within the outflow pathway. A next
step would be to combine the subdivided dissection method
with approaches such as the differential approach of Lo
et al.,48 to assess more subtle changes in 1 cell type induced
by dexamethasone, and as approached by Liton et al.46 and
Liu et al.47 to assess differences in POAG versus non-POAG
tissue. Since the cells from each subdivision of the outflow
pathway appear to retain many of their characteristics for
several generations in culture, and cells grow well from
POAG eyes that have been opened and supported in medium
within 12 h of death, a series of comparisons of expression
levels between the same cell types from control and POAG
eyes would be an attractive approach by which to look for
differences that would offer new clues to the etiology of
POAG, or to test existing hypotheses. The shortcoming of
looking only at the transcription level to infer cell function
can now be partially overcome by coupling such experi-
ments with recently greatly improved techniques for iden-
tifying the portfolio of expressed proteins and glycoproteins
from tissues and cells using mass spectrometry.69,70 It is
hoped that the present results will stimulate new hypotheses
toward understanding normal outflow physiology, and the
pathophysiology of POAG.
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